HRGN
Harvard Apparatus Regenerative Technology Inc.
Price Chart
Latest Quote
$1.24
+0.00 (+0.00%)
Current Price
| Previous Close | $1.24 |
| Open | $1.15 |
| Day High | $1.39 |
| Day Low | $1.04 |
| Volume | 2,601 |
Stock Information
| Shares Outstanding | 17.58M |
| Total Debt | $173K |
| Cash Equivalents | $419K |
| Revenue | $885K |
| Net Income | $-6.81M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $21.71M |
| EPS (TTM) | $-0.46 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $21.47M |
| Sales | $885K |
| Income | $-6.81M |
| Book/sh | $0.01 |
| Cash/sh | $0.02 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 0.26 |
| Current Ratio | 0.53 |
| Debt/Eq | 188.04 |
Returns & Margins
| ROA | -164.28% |
| ROE | -636.54% |
| Gross Margin | 7.46% |
| Operating Margin | -710.62% |
Ownership
| Insider Ownership | 51.09% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 24.53 |
| P/B | 247.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.17 |
| SMA50 | $1.38 |
| SMA200 | $1.70 |
| RSI | 52.98 |
| ATR | 0.0775 |
| Shares Float | 8.63M |
| Short Float | 6.77% |
| Short Ratio | 3.35 |
Performance History
| Week | -4.63% |
| Month | -11.79% |
| Quarter | -26.36% |
| 6 Months | -33.24% |
| YTD | -32.88% |
| Year | -22.33% |
| 3 Years | -74.37% |
| 5 Years | +2.07% |
| 10 Years | -94.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $1.24 | 0 |
| 2026-06-22 | $1.24 | 0 |
| 2026-06-18 | $1.24 | 200 |
| 2026-06-17 | $1.07 | 600 |
| 2026-06-16 | $1.14 | 200 |
| 2026-06-15 | $1.29 | 1,800 |
| 2026-06-12 | $1.08 | 0 |
| 2026-06-11 | $1.08 | 200 |
| 2026-06-10 | $1.10 | 2,000 |
| 2026-06-09 | $1.08 | 0 |
| 2026-06-08 | $1.08 | 0 |
| 2026-06-05 | $1.08 | 0 |
| 2026-06-04 | $1.08 | 600 |
| 2026-06-03 | $1.12 | 1,700 |
| 2026-06-02 | $1.19 | 200 |
| 2026-06-01 | $1.15 | 1,500 |
| 2026-05-29 | $1.19 | 900 |
| 2026-05-28 | $1.30 | 500 |
| 2026-05-27 | $1.31 | 200 |
| 2026-05-26 | $1.40 | 0 |
About Harvard Apparatus Regenerative Technology Inc.
Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects. The company's lead product candidate is Cellspan Esophageal Implant for the treatment of severe esophageal disease. It's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs; and product candidates to treat conditions of the esophagus, including traumatic injury, caustic burns, tissue damage following chemoradiation therapy, birth defects, and reconstruction of the colon and uterus wound repair. The company also sells consumer health products that focuses on personal healthcare, including dietary supplements. Harvard Apparatus Regenerative Technology Inc. was formerly known as Biostage, Inc. and changed its name to Harvard Apparatus Regenerative Technology Inc. in July 2023. The company was founded in 2009 and is headquartered in Holliston, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on HRGN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $270,000 | $24,000 | $0 | - |
| Cost Of Revenue | $270,000 | $24,000 | $0 | - |
| Total Revenue | $430,000 | $103,000 | $0 | $0 |
| Operating Revenue | $430,000 | $103,000 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $38,000 | $14,000 | $9,000 | - |
| Total Expenses | $8,156,000 | $9,093,000 | $6,153,000 | $8,471,000 |
| Net Non Operating Interest Income Expense | $-6,000 | $50,000 | $-9,000 | - |
| Interest Expense Non Operating | $38,000 | $14,000 | $9,000 | - |
| Operating Expense | $7,886,000 | $9,069,000 | $6,153,000 | $8,471,000 |
| Selling And Marketing Expense | $554,000 | $294,000 | $0 | - |
| General And Administrative Expense | $5,022,000 | $5,713,000 | $4,411,000 | $7,044,000 |
| Other Income Expense | - | $-5,000 | $89,000 | $493,000 |
| Other Non Operating Income Expenses | - | $-5,000 | $87,000 | $70,000 |
| Other Operating Expenses | - | - | - | $-165,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Net Interest Income | $-6,000 | $50,000 | $-9,000 | - |
| Interest Income | $32,000 | $64,000 | $0 | - |
| Normalized Income | $-7,732,000 | $-8,945,000 | $-6,075,000 | $-8,401,000 |
| Net Income From Continuing And Discontinued Operation | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Total Operating Income As Reported | $-7,726,000 | $-8,990,000 | $-6,153,000 | $-8,636,000 |
| Net Income Common Stockholders | $-7,732,000 | $-9,022,000 | $-6,253,000 | $-7,978,000 |
| Net Income | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Net Income Including Noncontrolling Interests | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Net Income Continuous Operations | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Pretax Income | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Interest Income Non Operating | $32,000 | $64,000 | $0 | - |
| Operating Income | $-7,726,000 | $-8,990,000 | $-6,153,000 | $-8,471,000 |
| Gross Profit | $160,000 | $79,000 | $0 | $0 |
| Special Income Charges | - | - | $0 | $408,000 |
| Per Share | ||||
| Diluted EPS | $-0.52 | $-0.67 | $-0.55 | $-0.79 |
| Basic EPS | $-0.52 | $-0.67 | $-0.55 | $-0.79 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,527,000 | $-8,797,000 | $-5,992,000 | $-8,787,000 |
| Reconciled Depreciation | $167,000 | $134,000 | $74,000 | $107,000 |
| EBITDA (Bullshit earnings) | $-7,527,000 | $-8,797,000 | $-5,990,000 | $-8,364,000 |
| EBIT | $-7,694,000 | $-8,931,000 | $-6,064,000 | $-8,471,000 |
| Diluted Average Shares | $14,789,332 | $13,455,666 | $11,349,610 | $10,062,000 |
| Basic Average Shares | $14,789,332 | $13,455,666 | $11,349,610 | $10,062,000 |
| Diluted NI Availto Com Stockholders | $-7,732,000 | $-9,022,000 | $-6,253,000 | $-7,978,000 |
| Research And Development | $2,310,000 | $3,062,000 | $1,742,000 | $1,592,000 |
| Selling General And Administration | $5,576,000 | $6,007,000 | $4,411,000 | $7,044,000 |
| Other Gand A | $5,022,000 | $5,713,000 | $4,411,000 | $7,044,000 |
| Preferred Stock Dividends | - | $77,000 | $180,000 | - |
| Total Unusual Items | - | - | $2,000 | $423,000 |
| Total Unusual Items Excluding Goodwill | - | - | $2,000 | $423,000 |
| Gain On Sale Of Security | - | - | $2,000 | $15,000 |
| Other Special Charges | - | - | - | $-408,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,222,000 | $1,646,000 | $989,000 | $-3,029,000 |
| Total Assets | $4,442,000 | $2,614,000 | $2,400,000 | $1,866,000 |
| Total Non Current Assets | $1,208,000 | $1,831,000 | $806,000 | $279,000 |
| Non Current Prepaid Assets | $904,000 | $1,214,000 | $0 | - |
| Non Current Deferred Assets | $0 | $544,000 | $610,000 | $0 |
| Current Assets | $3,234,000 | $783,000 | $1,594,000 | $1,587,000 |
| Other Current Assets | $263,000 | $8,000 | $8,000 | $12,000 |
| Prepaid Assets | $174,000 | $289,000 | $345,000 | $283,000 |
| Inventory | $80,000 | $50,000 | $0 | - |
| Receivables | $231,000 | $4,000 | $0 | $0 |
| Accounts Receivable | $231,000 | $4,000 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $2,486,000 | $432,000 | $1,241,000 | $1,242,000 |
| Cash And Cash Equivalents | $2,486,000 | $432,000 | $1,241,000 | $1,242,000 |
| Restricted Cash | - | - | $0 | $50,000 |
| Cash Financial | - | - | $1,241,000 | $1,242,000 |
| Debt | ||||
| Total Debt | $294,000 | $48,000 | $147,000 | $169,000 |
| Long Term Debt And Capital Lease Obligation | $199,000 | $0 | $48,000 | $59,000 |
| Current Debt And Capital Lease Obligation | $95,000 | $48,000 | $99,000 | $110,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,220,000 | $968,000 | $1,411,000 | $4,895,000 |
| Total Non Current Liabilities Net Minority Interest | $199,000 | $0 | $48,000 | $59,000 |
| Current Liabilities | $1,021,000 | $968,000 | $1,363,000 | $4,836,000 |
| Payables And Accrued Expenses | $926,000 | $919,000 | $1,252,000 | $4,724,000 |
| Payables | $705,000 | $445,000 | $682,000 | $676,000 |
| Other Payable | $253,000 | - | - | - |
| Accounts Payable | $452,000 | $445,000 | $682,000 | $676,000 |
| Other Current Liabilities | - | $1,000 | $12,000 | $2,000 |
| Equity | ||||
| Common Stock Equity | $3,222,000 | $1,646,000 | $-3,191,000 | $-3,029,000 |
| Total Equity Gross Minority Interest | $3,222,000 | $1,646,000 | $989,000 | $-3,029,000 |
| Stockholders Equity | $3,222,000 | $1,646,000 | $989,000 | $-3,029,000 |
| Gains Losses Not Affecting Retained Earnings | $-6,000 | $0 | - | - |
| Other Equity Adjustments | $-6,000 | - | - | - |
| Retained Earnings | $-99,688,000 | $-91,956,000 | $-83,011,000 | $-76,938,000 |
| Preferred Stock Equity | - | - | $4,180,000 | - |
| Other | ||||
| Ordinary Shares Number | $15,918,979 | $13,947,324 | $12,174,467 | $10,760,871 |
| Share Issued | $15,918,979 | $13,947,324 | $12,174,467 | $10,760,871 |
| Tangible Book Value | $3,222,000 | $1,646,000 | $-3,191,000 | $-3,029,000 |
| Invested Capital | $3,222,000 | $1,646,000 | $-3,191,000 | $-3,029,000 |
| Working Capital | $2,213,000 | $-185,000 | $231,000 | $-3,249,000 |
| Capital Lease Obligations | $294,000 | $48,000 | $147,000 | $169,000 |
| Total Capitalization | $3,222,000 | $1,646,000 | $989,000 | $-3,029,000 |
| Additional Paid In Capital | $102,757,000 | $93,463,000 | $79,698,000 | $73,801,000 |
| Capital Stock | $159,000 | $139,000 | $4,302,000 | $108,000 |
| Common Stock | $159,000 | $139,000 | $122,000 | $108,000 |
| Long Term Capital Lease Obligation | $199,000 | $0 | $48,000 | $59,000 |
| Current Capital Lease Obligation | $95,000 | $48,000 | $99,000 | $110,000 |
| Current Accrued Expenses | $221,000 | $474,000 | $570,000 | $4,048,000 |
| Net PPE | $304,000 | $73,000 | $196,000 | $279,000 |
| Accumulated Depreciation | $-1,476,000 | $-1,462,000 | $-1,427,000 | $-2,504,000 |
| Gross PPE | $1,780,000 | $1,535,000 | $1,623,000 | $2,783,000 |
| Leases | $35,000 | $35,000 | $35,000 | $584,000 |
| Other Properties | $293,000 | $48,000 | $147,000 | $169,000 |
| Machinery Furniture Equipment | $1,452,000 | $1,452,000 | $1,441,000 | $2,030,000 |
| Properties | $0 | $0 | $0 | $0 |
| Preferred Stock | - | $0 | $4,180,000 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,852,000 | $-6,950,000 | $-5,111,000 | $-2,628,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,852,000 | $-6,939,000 | $-5,106,000 | $-2,628,000 |
| Cash Flow From Continuing Operating Activities | $-4,852,000 | $-6,939,000 | $-5,106,000 | $-2,628,000 |
| Operating Gains Losses | - | - | $-2,000 | $-423,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-11,000 | $-5,000 | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $-11,000 | $-5,000 | $0 |
| Capital Expenditure | - | $-11,000 | $-5,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $6,482,000 | $5,992,000 | $5,060,000 | $2,844,000 |
| Financing Cash Flow | $6,912,000 | $6,141,000 | $5,060,000 | $2,844,000 |
| Cash Flow From Continuing Financing Activities | $6,912,000 | $6,141,000 | $5,060,000 | $2,844,000 |
| Net Common Stock Issuance | $6,482,000 | $5,992,000 | $5,060,000 | $2,844,000 |
| Common Stock Issuance | $6,482,000 | $5,992,000 | $5,060,000 | $2,844,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-500,000 | $0 | - | - |
| Issuance Of Debt | $500,000 | $0 | - | $0 |
| Interest Paid Supplemental Data | $38,000 | $14,000 | $9,000 | - |
| End Cash Position | $2,486,000 | $432,000 | $1,241,000 | $1,292,000 |
| Beginning Cash Position | $432,000 | $1,241,000 | $1,292,000 | $1,076,000 |
| Effect Of Exchange Rate Changes | $-6,000 | $0 | - | - |
| Changes In Cash | $2,060,000 | $-809,000 | $-51,000 | $216,000 |
| Proceeds From Stock Option Exercised | $430,000 | $149,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $0 | $0 | - | $0 |
| Net Short Term Debt Issuance | $0 | $0 | - | - |
| Short Term Debt Payments | $-500,000 | $0 | - | - |
| Short Term Debt Issuance | $500,000 | $0 | - | - |
| Net Investment Purchase And Sale | $0 | $0 | $0 | - |
| Sale Of Investment | $0 | $2,523,000 | $0 | - |
| Purchase Of Investment | $0 | $-2,523,000 | $0 | - |
| Net PPE Purchase And Sale | $0 | $-11,000 | $-5,000 | $0 |
| Purchase Of PPE | $0 | $-11,000 | $-5,000 | $0 |
| Change In Working Capital | $311,000 | $-1,589,000 | $-136,000 | $4,686,000 |
| Change In Other Working Capital | $544,000 | $66,000 | $-610,000 | - |
| Change In Other Current Liabilities | $-152,000 | $-99,000 | $-22,000 | - |
| Change In Payables And Accrued Expense | $-309,000 | $-344,000 | $554,000 | $4,380,000 |
| Change In Accrued Expense | $-254,000 | $-107,000 | $548,000 | $3,735,000 |
| Change In Payable | $-55,000 | $-237,000 | $6,000 | $645,000 |
| Change In Account Payable | $7,000 | $-237,000 | $6,000 | $645,000 |
| Change In Prepaid Assets | $485,000 | $-1,158,000 | $-58,000 | $229,000 |
| Change In Inventory | $-30,000 | $-50,000 | $0 | - |
| Change In Receivables | $-227,000 | $-4,000 | $0 | $77,000 |
| Changes In Account Receivables | $-227,000 | $-4,000 | $0 | - |
| Stock Based Compensation | $2,402,000 | $3,461,000 | $1,031,000 | $980,000 |
| Depreciation Amortization Depletion | $167,000 | $134,000 | $74,000 | $107,000 |
| Depreciation And Amortization | $167,000 | $134,000 | $74,000 | $107,000 |
| Depreciation | $167,000 | $134,000 | $74,000 | $107,000 |
| Net Income From Continuing Operations | $-7,732,000 | $-8,945,000 | $-6,073,000 | $-7,978,000 |
| Gain Loss On Investment Securities | - | - | $-2,000 | $-15,000 |
| Common Stock Payments | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-02-02